Solenic Medical, based in Addison, TX and led by CEO James Y. Lancaster, develops a device that uses alternating magnetic fields (AMF) generated from external coils to eradicate biofilm on the surface of medical implants. The company's initial product targets the metallic components of knee implants. Its pipeline aims to extend the AMF treatment to most metallic medical implants including hips, elbows and trauma devices. Solenic plans to commercialize this method for treating prosthetic joint infections (PJI). The company raised funding to support expansion of operations and its R&D sector. The articles do not provide operating metrics such as revenue or user counts.

Total raised

$5M

Funding rounds

1

Latest round

Series A

Latest activity

Jun 2023